Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates
about
In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotidesAnti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cellsAntisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cellsSelf-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activityT30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cellsSequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.DNA as therapeutics; an update.Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.Gene therapy for infectious diseasesVector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.CNS drug targeting: have we travelled in right path?Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries.Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.Native oligodeoxynucleotides specifically active against human immunodeficiency virus type 1 in vitro: a G-quartet-driven effect?Antisense 2'-O-alkyl oligoribonucleotides are efficient inhibitors of reverse transcription.In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.Development of antisense therapeutics. Implications for cancer gene therapy.Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads.Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
P2860
Q27477597-7B78AED5-0CAC-42FB-9BCD-F18F3338CA47Q28367621-3FFBA3F2-19AB-479A-8EF2-443AE58EE062Q28369354-8D957BCF-7812-4B4D-AD2F-CF2E03DE79E0Q28378628-88802286-F8AD-4D93-9222-9419C18A552CQ28378782-76391A81-1D3D-49B1-BC87-C6D95B6ACA4EQ28379170-DED3B938-E997-488A-8E71-DC0BEC8D3D09Q30452649-60B5A428-9A04-4AE8-BF00-C51AA1473A8AQ33804495-FDC7E12D-F080-4886-8F92-0052E95478CFQ33836499-8D0471CF-F103-4707-8338-5EA6D87D2868Q33903623-9A4B70CF-49BB-48D0-9232-FAB6001A5A61Q33992464-BD3B47B0-9B69-4E40-8C8D-4FECB09BBD89Q34239620-132E07BE-A8D5-4D2D-AB52-0E747862255FQ35870795-32573550-1319-4C7D-9D8A-9032EBD8C2F5Q36028877-5FC422CF-45FC-4E2A-9CCC-E5792D518794Q38127262-D71B1C85-5ACC-4047-AFE6-9E81F7160349Q38291471-FC769C83-CD33-4118-9880-38BA7387097CQ38329856-6B757AE8-78E6-45E1-90A1-A32C89AA5404Q38347917-E0C8D13F-8A3F-4078-986A-6B8B86B3FE29Q39683244-24A7C504-432A-4ADE-84C8-94A1E391658AQ39782719-31F620C1-B85C-4E7F-9D08-70931A5A1DEAQ40392535-A727AE83-B4B4-468A-B4FA-C11E532C79B9Q40547788-DB8E5346-815E-4D52-91EB-D54FF6F40AD3Q40667901-77776C81-AEFC-4773-99AC-5D2BAC7E2EBDQ40813351-D345CAFC-53C8-4A20-9F2A-86B9B1D5AA7DQ42280395-5393BB61-2410-46E0-B69A-FBAD1618372BQ43652182-938B7A4D-D1E8-4D4B-8BD2-31A9C1F2ECEB
P2860
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Long-term treatment of human i ...... gonucleotide phosphorothioates
@ast
Long-term treatment of human i ...... gonucleotide phosphorothioates
@en
Long-term treatment of human i ...... gonucleotide phosphorothioates
@nl
type
label
Long-term treatment of human i ...... gonucleotide phosphorothioates
@ast
Long-term treatment of human i ...... gonucleotide phosphorothioates
@en
Long-term treatment of human i ...... gonucleotide phosphorothioates
@nl
prefLabel
Long-term treatment of human i ...... gonucleotide phosphorothioates
@ast
Long-term treatment of human i ...... gonucleotide phosphorothioates
@en
Long-term treatment of human i ...... gonucleotide phosphorothioates
@nl
P2093
P2860
P356
P1476
Long-term treatment of human i ...... gonucleotide phosphorothioates
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.9.3860
P407
P50
P577
1993-05-01T00:00:00Z